Drug Identification Numbers (DINs)
- Abatacept IV (Orencia): 02282097
- Abatacept SC (Orencia): 02402475
- Adalimumab (Humira): 02258595
- Anakinra (Kineret): 02245913
- Belimumab (Benlysta): 02370050, 02370069
- Certolizumab (Cimzia): 02331675
- Denosumab (Prolia): 02343541
- Depomedrol: 00030759 (40 mg/mL), 00030767 (80 mg/mL)
- Etanercept (Enbrel): 02274728, 02242903
- Golimumab SC (Simponi): 02324784, 02324776
- Golimumab IV (Simponi): 02324776
- Infliximab (Remicade): 02244016
- Infliximab (Remsima): 02419483
- Rituximab (Rituxan): 02241927
- Rituximab (Truxima): 02478382
- Rituximab (Riximyo): 02498316
- Rituximab (Ruxience): 02495724
- Tocilizumab IV (Actemra): 02350092, 02350106, 02350114
- Tocilizumab SC (Actemra): 02424770
- Tofacitinib (Xeljanz): 02423898
- Viscosupplementation:
- 00000962325, 00000965294 (Synvisc),
- 00000965014 (Synvisc One),
- 00000963828 (Neovisc),
- 00000964573 (Durolane),
- 00096599996 (Euflexxa),
- 00000963631 (Suplasyn),
- 00000174625 (Orthovisc)